Boostrix tdap vaccine syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DR26FQQ1S
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,692
Award facts
- Contract value 100% obligated
- $18,692.27 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $18,692.27 delivery order to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine in 0.5ml syringes. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of November 18, 2025, issued on November 17, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The vaccine will support federal medical procurement needs, particularly for military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive global pharmaceutical support vehicle enables AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including vaccines, medications, syringes, and medical devices. The IDC serves customers including the Defense Health Agency and U.S. Coast Guard, positioning AmerisourceBergen as a critical vendor for federal medical supply needs. As a major pharmaceutical distributor, AmerisourceBergen has demonstrated capability to meet federal procurement requirements through competitive, non-set-aside contract awards across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FQQ1S?
SPE2DR26FQQ1S was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 17, 2025.
How much is contract SPE2DR26FQQ1S worth?
The government has obligated $18,692 on SPE2DR26FQQ1S.
Is contract SPE2DR26FQQ1S an order under another contract?
Yes. SPE2DR26FQQ1S is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQQ1S competed?
The extent of competition for SPE2DR26FQQ1S was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award